Potential Prognostic Impact of High-Sensitivity C-Reactive Protein in the Analysis of Whole-Heart Myocardial

Karolina Melinyte-Ankudavice1,2, Gabriele Jakuskaite1,2, Gryte Galnaitiene3

  • 1Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

PubMed

Insights

High-sensitivity C-reactive protein (hs-CRP) levels strongly correlate with early left atrial strain changes in non-ischemic dilated cardiomyopathy (NIDCM) patients. This finding may help predict heart failure progression.

Area of Science:

  • Cardiology
  • Biomarkers
  • Cardiac Mechanics

Background:

  • Non-ischemic dilated cardiomyopathy (NIDCM) is a significant cause of heart failure (HF).
  • Detailed investigation of whole-heart mechanics and morphometry is crucial for understanding NIDCM.
  • Existing biomarkers require evaluation for their association with early cardiac changes.

Purpose of the Study:

  • To investigate the relationship between commonly used biomarkers and early alterations in whole-heart myocardial mechanics and morphometry in NIDCM patients.
  • To identify predictive biomarkers for early changes in cardiac function.

Main Methods:

  • Prospective single-center study with 98 NIDCM patients at diagnosis and 42 at 1-year follow-up.
  • Cardiac magnetic resonance imaging (CMR) used for whole-heart myocardial mechanics and morphometry analysis.
  • Assessment of biomarkers including hs-CRP, troponin I, BNP, and others at diagnosis.

Main Results:

  • High-sensitivity C-reactive protein (hs-CRP) showed the strongest correlation with 1-year changes in left atrial global longitudinal strain (LA GLS) (r = -0.659, P < .001).
  • An hs-CRP cut-off value of 3.6 mg/L predicted reduced LA GLS with 100% sensitivity and 87% specificity (AUC = 0.833).
  • Other biomarkers had weaker associations, primarily with left heart parameters.

Conclusions:

  • In NIDCM patients, key heart failure biomarkers are linked to early changes in left-heart mechanics and morphometrics.
  • Initial hs-CRP levels demonstrate the strongest relationship with early LA GLS changes, suggesting its prognostic value.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
313
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
801
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
399